• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩大 WHIM 综合征中 CXCR4 变体谱:整合临床和功能数据进行变体解释。

Expanding CXCR4 variant landscape in WHIM syndrome: integrating clinical and functional data for variant interpretation.

机构信息

X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.

Invitae, San Francisco, CA, United States.

出版信息

Front Immunol. 2024 Jul 8;15:1411141. doi: 10.3389/fimmu.2024.1411141. eCollection 2024.

DOI:10.3389/fimmu.2024.1411141
PMID:39040098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11260667/
Abstract

Warts, Hypogammaglobulinemia, Infections, Myelokathexis (WHIM) syndrome is a rare, combined immunodeficiency disease predominantly caused by gain-of-function variants in the gene that typically results in truncation of the carboxyl terminus of C-X-C chemokine receptor type 4 (CXCR4) leading to impaired leukocyte egress from bone marrow to peripheral blood. Diagnosis of WHIM syndrome continues to be challenging and is often made through clinical observations and/or genetic testing. Detection of a pathogenic variant in an affected individual supports the diagnosis of WHIM syndrome but relies on an appropriate annotation of disease-causing variants. Understanding the genotypic-phenotypic associations in WHIM syndrome has the potential to improve time to diagnosis and guide appropriate clinical management, resulting in a true example of precision medicine. This article provides an overview of the spectrum of variants in WHIM syndrome and summarizes the various lines of clinical and functional evidence that can support interpretation of newly identified variants.

摘要

疣、低丙种球蛋白血症、感染、骨髓嗜中性粒细胞减少(WHIM)综合征是一种罕见的联合免疫缺陷病,主要由 基因的功能获得性变异引起,通常导致 C-X-C 趋化因子受体 4(CXCR4)羧基末端截断,导致白细胞从骨髓外溢到外周血减少。WHIM 综合征的诊断仍然具有挑战性,通常通过临床观察和/或基因检测来做出。在受影响的个体中检测到致病性 变异可支持 WHIM 综合征的诊断,但依赖于对致病变异的适当注释。了解 WHIM 综合征的基因型-表型相关性有可能提高诊断时间并指导适当的临床管理,从而真正实现精准医学。本文概述了 WHIM 综合征中 变异的范围,并总结了各种临床和功能证据,这些证据可以支持对新鉴定的变异的解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9601/11260667/6d812ff9f2aa/fimmu-15-1411141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9601/11260667/57220af4bd05/fimmu-15-1411141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9601/11260667/6d812ff9f2aa/fimmu-15-1411141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9601/11260667/57220af4bd05/fimmu-15-1411141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9601/11260667/6d812ff9f2aa/fimmu-15-1411141-g002.jpg

相似文献

1
Expanding CXCR4 variant landscape in WHIM syndrome: integrating clinical and functional data for variant interpretation.扩大 WHIM 综合征中 CXCR4 变体谱:整合临床和功能数据进行变体解释。
Front Immunol. 2024 Jul 8;15:1411141. doi: 10.3389/fimmu.2024.1411141. eCollection 2024.
2
Unexpected diagnosis of WHIM syndrome in refractory autoimmune cytopenia.WHIM 综合征致难治性自身免疫性血细胞减少症的意外诊断
Blood Adv. 2024 Oct 8;8(19):5126-5136. doi: 10.1182/bloodadvances.2024013301.
3
Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4 variants.WHIM 综合征的基因型-表型相关性:CXCR4 变异的系统特征分析。
Genes Immun. 2022 Sep;23(6):196-204. doi: 10.1038/s41435-022-00181-9. Epub 2022 Sep 12.
4
Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.WHIM 综合征 66 例儿科和成年患者国际队列的疾病进展。
J Clin Immunol. 2022 Nov;42(8):1748-1765. doi: 10.1007/s10875-022-01312-7. Epub 2022 Aug 10.
5
Genetics on a WHIM.凭兴致了解遗传学。
Br J Haematol. 2014 Jan;164(1):15-23. doi: 10.1111/bjh.12574. Epub 2013 Sep 20.
6
Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome.疣、低丙种球蛋白血症、感染和骨髓嗜中性粒细胞减少(WHIM)综合征的临床和遗传特征。
Curr Mol Med. 2011 Jun;11(4):317-25. doi: 10.2174/156652411795677963.
7
WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.WHIM 综合征由趋化因子受体 CXCR4 的羧基末端单个氨基酸取代引起。
Blood. 2012 Jul 5;120(1):181-9. doi: 10.1182/blood-2011-12-395608. Epub 2012 May 17.
8
Recurrent CXCR4 sequence variation in a girl with WHIM syndrome.一名患有WHIM综合征的女孩中CXCR4序列反复出现变异。
Eur J Haematol. 2007 Jan;78(1):86-8. doi: 10.1111/j.1600-0609.2006.00779.x. Epub 2006 Nov 6.
9
Tetralogy of fallot is an uncommon manifestation of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome.法洛四联症是疣、低丙种球蛋白血症、感染和骨髓发育不良综合征的一种不常见表现。
J Pediatr. 2012 Oct;161(4):763-5. doi: 10.1016/j.jpeds.2012.05.058. Epub 2012 Jun 27.
10
WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.在移植了用C端截短的CXCR4转导的健康人类干细胞的NOD/SCID小鼠异种移植模型中重现了WHIM综合征髓细胞减少症。
Blood. 2007 Jan 1;109(1):78-84. doi: 10.1182/blood-2006-05-025296. Epub 2006 Aug 31.

引用本文的文献

1
Heterogeneous phenotype of a Chinese Familial WHIM syndrome with CXCR4 gain-of-function mutation.中国家族性 WHIM 综合征伴 CXCR4 功能获得性突变的异质性表型。
Front Immunol. 2024 Nov 7;15:1460990. doi: 10.3389/fimmu.2024.1460990. eCollection 2024.

本文引用的文献

1
A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome.一项针对 WHIM 综合征的 mavorixafor(一种 CXCR4 拮抗剂)的 3 期随机试验。
Blood. 2024 Jul 4;144(1):35-45. doi: 10.1182/blood.2023022658.
2
Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome.尽管携带 CXCR4Leu317fsX3 突变导致 WHIM 综合征的患者存在内化和β-arrestin 募集受损,但 G 蛋白信号转导减少。
JCI Insight. 2023 Mar 8;8(5):e145688. doi: 10.1172/jci.insight.145688.
3
Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4 variants.
WHIM 综合征的基因型-表型相关性:CXCR4 变异的系统特征分析。
Genes Immun. 2022 Sep;23(6):196-204. doi: 10.1038/s41435-022-00181-9. Epub 2022 Sep 12.
4
Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.WHIM 综合征 66 例儿科和成年患者国际队列的疾病进展。
J Clin Immunol. 2022 Nov;42(8):1748-1765. doi: 10.1007/s10875-022-01312-7. Epub 2022 Aug 10.
5
How Functional Genomics Can Keep Pace With VUS Identification.功能基因组学如何跟上意义未明变异(VUS)识别的步伐。
Front Cardiovasc Med. 2022 Jul 4;9:900431. doi: 10.3389/fcvm.2022.900431. eCollection 2022.
6
Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients.细胞膜上 CXCR4 动力学的改变会损害 WHIM 综合征患者的定向细胞迁移。
Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2119483119. doi: 10.1073/pnas.2119483119. Epub 2022 May 19.
7
Case Report: A Novel Mutation in a Chinese Child With Kawasaki Disease Causing WHIM Syndrome.病例报告:中国一名川崎病合并 WHIM 综合征患儿的新型突变。
Front Immunol. 2022 Apr 13;13:857527. doi: 10.3389/fimmu.2022.857527. eCollection 2022.
8
Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4.鉴定一种新型 WHIM 综合征突变体,揭示了趋化因子受体 CXCR4 调控的机制差异。
J Biol Chem. 2022 Feb;298(2):101551. doi: 10.1016/j.jbc.2021.101551. Epub 2021 Dec 30.
9
Biallelic CXCR2 loss-of-function mutations define a distinct congenital neutropenia entity.双等位基因CXCR2功能丧失突变定义了一种独特的先天性中性粒细胞减少症实体。
Haematologica. 2022 Mar 1;107(3):765-769. doi: 10.3324/haematol.2021.279254.
10
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome.WHIM 综合征治疗中口服 CXCR4 拮抗剂 mavorixafor 的 2 期临床试验结果。
Blood. 2020 Dec 24;136(26):2994-3003. doi: 10.1182/blood.2020007197.